An updated meta-analysis by Abdelaziz et al., analyzed 15 RCTs comparing aspirin to control for primary prevention. The analysis included 165,502 patients with weighted mean follow-up of 6.4 years. It found no difference in the rate of death or CV death between the aspirin and control groups. Rates of MI (2.07% v 2.35%) and ischemic strokes (1.29% v 1.49%) differed significantly in favor of aspirin for reducing risks (NNT 357 and 500, respectively). Aspirin, however, had a statistically significant higher risk of major bleeding (1.47% v 1.02%).
Does aspirin have a role for the primary prevention of CVD? If so, how do you decide which patients may benefit?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.